Staff Profile

Director of National Poisons Information Service (Newcastle) and UK Teratology Information Service September 2019-

Medical Director, Regional Drugs and Therapeutics Centre, 2019-

Consultant Physician and Clinical Toxicologist, Newcastle Hospitals NHS Foundation Trust

Fellowship of Royal College of Physicians (Edinburgh) 2007

Fellowship of Royal College of Physicians (London) 2013

Board member European Association of Poisons Centres and Clinical Toxicologists (EAPCCT)

Executive Editor, British Journal of Clinical Pharmacology 2021-

Member MRCP UK Part 1 Standard-setting Group 2023-

Member British Pharmacopoeia Commission Herbal and Complementary Medicines Expert Advisory Group 2023-

External Examiner, Diploma/Masters in Medical Toxicology, Cardiff University 2023-

External Examiner, MSc in Translational Medicine, Oxford University 2023-

External Clinical Adviser, Health Service Ombudsman

Previous:

Member of MHRA ISAC (Independent Scientific and Advisory Committee) 2007-2014

Member of MHRA PEAG (Pharmacovigilance Expert Advisory Group) 2011- 2023

Member MRCP UK Part 1 Specialty Question-Writing Group Clinical Pharmacology & Therapeutics 2007-2015

Member MRCP UK Part 1 Exam Board 2015-2022 

Chief External Examiner, Brighton & Sussex Medical School 2018-2022

CPD Lead, UK National Poisons Information Service (NPIS) 2016-2020

Module Leader, MRes Experimental Medicine and Therapeutics MMB8005

Lecturer, MRes Drug Discovery & Development MMB8006

Lecturer, BSc Pharmacology Advanced Pharmacogenetics PED3005 & Drug Discovery & Development PED3007

External Examiner, Diploma/Masters in Medical Toxicology, Cardiff University 2023-

External Examiner, MSc in Translational Medicine, Oxford University 2023-

Member MRCP UK Part 1 Standard-setting Group 2023-

Previous:

Lecturer, Diploma in Clinical Research MCR 8008

Lecturer, MRes Toxicology module MMB8032

Member MRCP(UK) Part 1 Exam Board 2015-2022  

Course Director, Clinical Pharmacology & Therapeutics course, Stage 4 MBBS 2015-2020

NPIS CPD Lead, 2016-2020

External Examiner Therapeutics, Brighton & Sussex Medical School 2018-2022

My principal research interest is management of poisoning and adverse drug reactions to antidotes.

My research aims to optimise acetylcysteine treatment regimens for paracetamol poisoning to reduce adverse reactions without compromising efficacy. I devised using pharmacokinetic modelling a shorter 12h acetylcysteine regimen. I was the Principal Investigator in Newcastle for the Scottish and Newcastle Anti-Emetic Pre-Treatment in Paracetamol Poisoning (SNAP) clinical trial which showed this shorter 12h regimen of acetylcysteine reduced the incidence of vomiting and anaphylactoid reactions (published in Lancet 2013).

I subsequently devised a clinical protocol (Scottish and Newcastle Acetylcysteine protocol) which was implemented in clinical practice in several hospitals in the UK and was audited for effectiveness compared to the conventional 21h acetylcysteine regimen. This audit showed that the SNAP regimen was as effective as the conventional 21h regimen and was associated with fewer adverse reactions.(published 2019)

In May 2023, the Royal College of Emergency Medicine (RCEM), National Poisons Information Service (NPIS) and British Association for the studyof the Liver (BASL) issued a joint position statement recommending the SNAP regimen as the standard of care for treatment of paracetamol overdose in the UK.

• Articles

  • Hughes BW, Gray LA, Bradberry SM, Sandilands EA, Thanacoody RH, Coulson JM. Metformin-associated lactic acidosis reported to the United Kingdom National Poisons Information Service (NPIS) between 2010 and 2019: a ten-year retrospective analysis. Clinical Toxicology 2023, 61(6), 445-452.
  • Haden M, Wheatley N, Gray LA, Bradberry SM, Sandilands EA, Thanacoody RH, Coulson J. Potential cyanide poisoning reported to the UK national poisons information service: 2008–2019. Clinical Toxicology 2022, 60(9), 1051-1058.
  • Gentile D, Adams R, Klatka M, Bradberry S, Gray L, Thanacoody R, Jackson G, Sandilands E. Carbon monoxide exposures reported to the UK National Poisons Information Service: a 4-year study. Journal of Public Health 2022, 44(3), 565-574.
  • Jagpal PS, Williams HA, Eddleston M, Lalloo D, Warrell D, Sandilands EA, Thanacoody R, Gray L, Bradberry SM. Bites by exotic snakes reported to the UK National Poisons Information Service 2009–2020. Clinical Toxicology 2022, 60(9), 1044-1050.
  • Lamb T, Stewart D, Warrell D, Lalloo D, Jagpal P, Jones D, Thanacoody R, Gray L, Eddleston M. Moderate-to-severe Vipera berus envenoming requiring ViperaTAb antivenom therapy in the UK. Clinical Toxicology 2021, 59(11), 992-1001.
  • Thanacoody R. Principles of assessment and diagnosis of the poisoned patient. Medicine 2020, 48(3), 156-159.
  • Pettie JM, Caparrotta TM, Hunter RW, EMorrison EE, David M Wood DM, Dargan PI, Thanacoody RH, Thomas SHL, Elamin MEMO, Francis B, Webb DJ, Sandilands EA, Eddleston M, Dear JW. Safety and Efficacy of the SNAP 12-hour Acetylcysteine Regimen for the Treatment of Paracetamol Overdose. EClinicalMedicine 2019, 11, 11-17.
  • Brinkman DJ, Tichelaar J, Mokkink LB, Christiaens T, Likic R, Maciulaitis R, Costa J, Sanz EJ, Maxwell SR, Richir MC, van Agtmael MA, EACPT and NOTIP. Education Working Group of the European Association for Clinical Pharmacology and Therapeutics (EACPT)and its affiliated Network of Teachers in Pharmacotherapy(NOTIP).Key Learning Outcomes for Clinical Pharmacology and Therapeutics Education in Europe: A Modified Delphi Study. Clinical Pharmacology & Therapeutics 2019, 104(2), 317-325.
  • Bailey GP, Rehman B, Wind K, Wood DM, Thanacoody R, Nash S, Archer JRH, Eddleston M, Thompson JP, Vale JA, Thomas SHL, Dargan PI. Taking stock: UK national antidote availability increasing, but further improvements are required. European Journal of Hospital Pharmacy 2016, 23(3), 145-150.
  • Thanacoody HKR. Serotonin syndrome. Medicine 2016, 44(2), 95-96.
  • Thanacoody HKR. Quinine and chloroquine. Medicine 2016, 44(3), 197-198.
  • Thanacoody HKR, Gilfillan C, Bradberry SM, Davies J, Jackson G, Vale JA, Thompson JP, Eddleston M, Thomas SHL. Management of poisoning with ethylene glycol and methanol in the UK: a prospective study conducted by the National Poisons Information Service (NPIS). Clinical Toxicology 2016, 54(2), 134-140.
  • Thanacoody R, Caravati EM, Troutman WG, Hojer J, Benson BE, Hoppu K, Erdman A, Bedry R, Megarbane B. Position paper update: Whole bowel irrigation for gastrointestinal decontamination of overdose patients. Clinical Toxicology 2015, 53(1), 5-12.
  • Kamour A, George N, Gwynette D, Cooper G, Lupton D, Eddleston M, Thompson JP, Vale JA, Thanacoody HK, Hill SL, Thomas SH. Increasing frequency of severe clinical toxicity after use of 2,4-dinitrophenol in the UK: a report from the National Poisons Information Service. Emergency Medicine Journal 2015, 32, 383-386.
  • Guilding C, Ball SG, Kennedy DJ, Thanacoody R. Development and Implementation of a Clinical Pharmacology, Therapeutics and Prescribing Strand for Newcastle University’s MBBS Degree Programme Using the British Pharmacological Society’s Core Curriculum for Medical Students. pA2 Online: E Journal of the British Pharmacological Society 2015, 13(3).
  • Bateman DN, Dear JW, Thanacoody HKR, Thomas SHL, Eddleston M, Sandilands EA, Coyle J, Cooper JG, Rodriguez A, Butcher I, Lewis SC, Vliegenthart ADB, Veiraiah A, Webb DJ, Gray A. Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning: a randomised controlled trial. The Lancet 2014, 383(9918), 697-704.
  • Kamour A, James D, Lupton DJ, Cooper G, Eddleston M, Vale A, Thompson JP, Thanacoody R, Hill SL, Thomas SHL. Patterns of presentation and clinical features of toxicity after reported use of ([2-aminopropyl]-2,3-dihydrobenzofurans), the 'benzofuran' compounds. A report from the United Kingdom National Poisons Information Service. Clinical Toxicology 2014, 52(10), 1025-1031.
  • Thanacoody HKR, Gray A, Dear JW, Coyle J, Sandilands EA, Webb DJ, Lewis S, Eddleston M, Thomas SHL, Bateman DN. Scottish and Newcastle Antiemetic Pre-treatment for paracetamol poisoning study (SNAP). BMC Pharmacology and Toxicology 2013, 14(1), 20.
  • Hojer R, Troutman WG, Hoppu K, Erdman A, Benson BE, Megarbane B, Thanacoody R, Bedry R, Caravati EM. Position paper update: ipecac syrup for gastrointestinal decontamination. Clinical Toxicology 2013, 51(3), 134-139.
  • Benson BE, Hoppu K, Troutman WG, Bedry R, Erdman A, Hojer J, Megarbane B, Thanacoody R, Caravati EM. Position paper update: gastric lavage for gastrointestinal decontamination. Clinical Toxicology 2013, 51(3), 140-146.
  • Thanacoody RH, Aldridge G, Laing W, Dargan PI, Nash S, Thompson JP, Vale A, Bateman N, Thomas S. National audit of antidote stocking in acute hospitals in the UK. Emergency Medicine Journal 2013, 30(5), 393-396.
  • Antoine DJ, Dear JW, Lewis PS, Platt V, Coyle J, Masson M, Thanacoody RH, Gray AJ, Webb DJ, Moggs JG, Bateman DN, Goldring CE, Park BK. Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital. Hepatology 2013, 58(2), 777-787.
  • Pettie J, Dow M, Sandilands EA, Thanacoody HKR, Bateman DN. An integrated care pathway improves the management of paracetamol poisoning. Emergency Medicine Journal 2012, 29, 482-486.
  • Thanacoody HKR. Thioridazine: The good and the Bad. Recent Patents in Anti-Infective Drug Discovery 2011, 6(2), 92-98.
  • Thanacoody HKR. Serotonin syndrome. Medicine 2011, 35(10), 556-557.
  • Thanacoody HKR, Jay J, Sherval J. The association between drug-related deaths and prior contact with hospital-based services. Scottish Medical Journal 2009, 54(1), 7-10.
  • Thanacoody R. Extracorporeal elimination in acute valproic acid poisoning. Clinical Toxicology 2009, 47(7), 609-616.
  • Thanacoody HKR. Chronic valproic acid intoxication: reversal by naloxone. BMJ Case Reports 2009, (9), bcr06.2009.1924.
  • Thanacoody HKR, Waring WS. Toxins affecting the cardiovascular system. Clinical Medicine 2008, 8(1), 92-95.
  • Thanacoody HKR, Good AM, Waring WS, Bateman DN. Survey of cases of paracetamol overdose in the UK referred to National Poisons Information Service (NPIS) consultants. Emergency Medicine Journal 2008, 25(3), 140-143.
  • Thanacoody HKR. Thioridazine: resurrection as an antimicrobial agent?. British Journal of Clinical Pharmacology 2007, 64(5), 566-574.
  • Thanacoody HKR. Serotonin syndrome. Medicine 2007, 35, 556-7.
  • Thanacoody HKR. Serotonin syndrome. Adv Drug React Bull 2007.
  • Thanacoody HKR. Gamma-hydroxybutyrate. Medicine 2007, 35, 619.
  • Thanacoody RHK, Daly AK, Reilly JG, Ferrier IN, Thomas SHL. Factors affecting drug concentrations and QT interval during thioridazine therapy. Clinical Pharmacology and Therapeutics 2007, 82(5), 555-565.
  • Salih ISM, Thanacoody RHK, McKay GA, Thomas SHL. Comparison of the effects of thioridazine and mesoridazine on the QT interval in healthy adults after single oral doses. Clinical Pharmacology and Therapeutics 2007, 82(5), 548-554.
  • Thanacoody HKR. Chronic valproic acid intoxication:reversal by naloxone. Emerg Med J 2007, 24, 677-8.
  • Thanacoody RHK, Daly AK, Reilly JG, Ferrier IN, Thomas SHL. Factors affecting steady-state plasma concentrations of thioridazine and its metabolites and electrocardiographic parameters of cardiac repolarisation in patients on chronic thioridazine therapy. Clinical Pharmacology and Therapeutics 2005, (submitted).
  • Thanacoody HKR, Thomas T, Purcell N, Graham K, Thomas SHL. [abstract] Spontaneous reporting of fatal adverse drug reactions in the north east of England. British Journal of Clinical Pharmacology 2005, 59(5), 649-650.
  • Thanacoody HKR, Daly AK, Thomas SH. Influence of CYP2D6 genotype on the QTc interval and plasma concentration of thioridazine and its metabolites of psychiatric patients taking chronic therapy. Clinical Pharmacology and Therapeutics 2003, 73, 77.
  • Thanacoody HKR, Daly AK, Thomas SHL. Influence of CYP2D6 and CYP2C19 genotypes on the QTc intervals of psychiatric patients taking thioridazine. British Journal of Clinical Pharmacology 2003, 55(4), 445-445.

• Book Chapters

  • Thanacoody HKR. Drug Interactions. In: Whittlesea C; Hodson K, ed. Clinical Pharmacy and Therapeutics. Amsterdam: Elsevier Health Sciences, 2018, pp.53-65.
  • Thanacoody HKR. Vitamins. In: Bateman DN, Jefferson RD, Thomas SHL, Thompson JP, Vale JA, ed. Oxford Desk Reference Toxicology. Oxford University Press, 2014, pp.176-177.
  • Thanacoody HKR. Serotonin syndrome. In: Bateman DN, Jefferson RD, Thomas SHL, Thompson JP, Vale JA, ed. Oxford Desk Reference Toxicology. Oxford University Press, 2014, pp.79-80.
  • Thanacoody HKR. Pharmacovigilance. In: Bateman DN, Jefferson RD, Thomas SHL, Thompson JP, Vale JA, ed. Oxford Desk Reference Toxicology. Oxford University Press, 2014, pp.14-15.
  • Thanacoody HKR. Methotrexate and other chemotherapeutic agents. In: Bateman DN, Jefferson RD, Thomas SHL, Thompson JP, Vale JA, ed. Oxford Desk Reference Toxicology. Oxford University Press, 2014, pp.168-171.
  • Thanacoody HKR. Malignant hyperpyrexia. In: Bateman DN, Jefferson RD, Thomas SHL, Thompson JP, Vale JA, ed. Oxford Desk Reference Toxicology. Oxford University Press, 2014, pp.81-82.
  • Thanacoody HKR. Drug and alcohol withdrawal. In: Bateman DN, Jefferson RD, Thomas SHL, Thompson JP, Vale JA, ed. Oxford Desk Reference Toxicology. Oxford University Press, 2014, pp.46-47.
  • Thanacoody HKR. Cyanide. In: Bateman DN, Jefferson RD, Thomas SHL, Thompson JP, Vale JA, ed. Oxford Desk Reference Toxicology. Oxford University Press, 2014, pp.229-230.
  • Thanacoody HKR. Drug interactions. In: Walker, R.S., Whittlesea, C, ed. Clinical Pharmacy & Therapeutics. Edinburgh, UK: Churchill Livingstone, 2012, pp.50-61.

• Conference Proceedings (inc. Abstracts)

  • Pucci M, Moyns E, Jutley G, Crisp R, Sandilands E, Gray L, Thanacoody R, Bradberry S. Recreational nitrous oxide abuse: Trends in enquiries to the UK National Poisons Information Service, 2011-2020. In: British Journal of Clinical Pharmacology. 2022, Wiley.
  • Thanacoody HKR, Nijhout HF, Reed MC, Thomas SHL. Mathematical modelling of the effect of late administration of a novel acetylcysteine regimen based on the SNAP trial on hepatic glutathione regeneration and hepatocyte death following simulated acetaminophen overdose. In: North American Congress of Clinical Toxicology. 2017, Vancouver: Taylor & Francis.
  • Thanacoody HKR, Nijhout HF, Reed MC, Thomas SHL. Mathematical modelling of the effect different acetylcysteine regimens on hepatic glutathione regeneration and hepatocyte death following simulated acetaminophen overdose. In: North American Congress of Clinical Toxicology. 2017, Vancouver: Taylor & Francis.
  • Thanacoody HKR, Thomas SHL. Pharmacokinetic modelling of a high dose acetylcysteine regimen based on the SNAP trial. In: 36th International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT). 2016, Madrid Spain: Taylor and Francis.
  • Thanacoody HKR, Thomas SHL. Pharmacokinetic modelling of a high dose acetylcysteine regimen based on the SNAP trial. In: 36th Congress of the European Association of Poisons Centres and Clinical Toxicologists. 2016, Madrid, Spain.
  • Thanacoody HKR, Nijhout FH, Reed MC, Thomas SHL. Mathematical modelling of the effect of a high dose acetylcysteine regimen based on the SNAP trial on hepatic glutathione regeneration and hepatocyte death. In: 36th International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT). 2016, Madrid, Spain: Taylor & Francis.
  • Elamin MEMO, Dunn M, Thomas SHL, Thanacoody HKR. Massive accidental caffeine overdose treated with continuous veno-venous haemodiafiltration (CVVHDF). In: 36th International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT). 2016, Madrid, Spain: Taylor & Francis.
  • Kamour A, James D, Lupton DJ, Cooper G, Eddleston M, Vale JA, Thompson JP, Thanacoody RHK, Hill SL, Thomas SHL. Toxicity after reported use of "benzofury" compounds ([2-aminopropyl]-2,3-dihydrobenzofurans) compared with mephedrone: A report from the UK National Poisons Information Service. In: XXXIV International Congress of EAPCCT. 2014, Brussels, Belgium: Informa Healthcare.
  • Kamour A, Gwynnette D, George N, Cooper G, Lupton DJ, Eddleston M, Thompson JP, Vale JA, Thanacoody RHK, Hill S, Thomas SHL. Severe toxicity after use of 2,4-dinitrophenol reported to the UK National Poisons Information Service. In: XXXIV International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT). 2014, Brussels, Belgium: Informa Healthcare.
  • Kamour A, James D, Spears R, Cooper G, Lupton DJ, Eddleston M, Thompson JP, Vale JA, Thanacoody RHK, Hill S, Thomas SHL. Patterns of presentation and clinical toxicity after reported use of alpha methyltryptamine in the United Kingdom: A report from the UK National Poisons Information Service. In: XXXIV International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT). 2014, Brussels, Belgium: Informa Healthcare.
  • Lam H, Hayhurst C, Holmes P, Thanacoody HKR, Thomas SHL. Subcutaneous self-injection of tetrodotoxin and ouabain. In: XXXIII International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT). 2013, Copenhagen, Denmark: Informa Healthcare.
  • Elamin M, Thanacoody R. Paracetamol-induced hepatotoxicity despite paracetamol concentrations below treatment threshold. In: International Congress of EAPCCT. 2013, Copenhagen, Denmark: Informa Healthcare.
  • Brown J, Thanacoody R. Paracetamol-induced hepatotoxicity at therapeutic doses. In: XXXIII International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT). 2013, Copenhagen, Denmark: Informa Healthcare.
  • Dear JW, Antoine DJ, Starkey-Lewis P, Platt V, Coyle J, Masson M, Thanacoody RH, Gray AJ, Webb DJ, Moggs JG, Bateman DN, Goldring CE, Park BK. Mechanistic biomarkers provide early and sensitive detection of paracetamol-induced acute liver injury at first presentation to hospital. In: XXXIII International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT). 2013, Copenhagen, Denmark: EAPCCT.
  • Thanacoody HKR. Clinical Toxicology of Ayurvedic Medicines. In: International Congress of EAPCCT. 2013, Copenhagen, Denmark: Informa Healthcare.
  • Thanacoody HKR, Weatherall I, Davies J, Thomas SHL. Treatment of severe toxic alcohol and glycol poisoning in the UK. In: International Congress of EAPCCT. 2012, London.
  • Thanacoody HKR, Weatherall I, Davies J, Thomas SHL. Toxic Alcohol and glycol poisoning in the UK- a 12 month prospective follow-up study. In: International Congress of EAPCCT. 2012, London.
  • Bradley S, George N, Thanacoody HKR. Heavy Metal Exposures Reported to the UK National Poisons Information Service 2008-2010. In: International Congress of the European Association of Poisons Centres and Clinical Toxicologists. 2012, London, UK: Informa Healthcare.
  • Thanacoody HKR, Aldridge G, Laing W, Nash S, Dargan PI, Vale JA, Bateman DN, Thompson JP, Thomas SHL. Antidote Stocking in Acute Hospitals in the United Kingdom. In: International Congress of the European Association of Poisons Centres and Clinical Toxicologists. 2012, London: Informa Healthcare.
  • Thanacoody HKR, Nash S, Vale JA, Bateman DN, Thompson JP, Dargan PI, Thomas SHL. Antidote Stocking in Acute Hospitals in the United Kingdom. In: International Congress of the European Association of the Poisons Centres and Clinical Toxicologists. 2012, London, UK: Informa Healthcare.
  • Amaral L, Abbate E, Boeree M, Gillespie S, Thanacoody R, Udwadia Z, vanIngen J, vanSoolingen D, Viveiros M. In vitro, ex vivo and in vivo studies indicate that neuroleptic thioridazine cures multi-drug resistant tuberculosis. In: 21st European Congress of Clinical Microbiology and Infectious Diseases and the 27th International Congress of Chemotherapy. 2011, Milan, Italy.
  • Weatherall I, Thanacoody HKR, Davies J, Cooper G, Thomas SHL. Characteristics of Toxic Alcohol and Glycol Poisoning in the UK. In: International Congress of the European Association of Poisons Centres and Clinical Toxicologists. 2011, Dubrovnik, Croatia: Informa Healthcare.
  • Pettie JM, Dow MA, Thanacoody HKR, Sandilands EA, Bateman DN. Integrated care pathway for the management of the paracetamol poisoned patient. In: XXX International Congress of EAPCCT. 2010, Bordeaux.
  • Thanacoody HKR. Clinical Toxicology of Ayurvedic Medicines. In: EAPCCT XXVIII International Congress. 2008, Seville, Spain: Informa Healthcare.
  • Thanacoody HKR, Daly AK, Reilly JG, Ferrier IN, Thomas SHL. Genetic factors influencing steady-state plasma concentrations of thioridazine and its metabolites. In: British Journal of Clinical Pharmacology: Meeting of the British Pharmacological Society Clinical Pharmacology Section. 2006, London, UK: Wiley-Blackwell Publishing Ltd.
  • Thanacoody HKR, Daly AK, Reilly JG, Ferrier IN, Thomas SHL. Effects of CYP2D6 genotype on QTc interval in recipients of thioridazine. In: British Journal of Clinical Pharmacology: Meeting of the British Pharmacological Society Clinical Pharmacology Section. 2006, London, UK: Wiley-Blackwell Publishing Ltd.
  • Salih I, Thanacoody HKR, McKay G, Thomas SHL. Effect of single-dose thioridazine and mesoridazine on the QTc interval in healthy adults. In: British Journal of Clinical Pharmacology: Meeting of the British Pharmacological Society Clinical Pharmacology Section. 2006, London, UK: Wiley-Blackwell Publishing Ltd.
  • Salih I, Thanacoody HKR, McKay G, Thomas SHL. Effect of single-dose chlorpromazine on the QTc interval in healthy adult volunteers. In: British Journal of Clinical Pharmacology: Meeting of the British Pharmacological Society Clinical Pharmacology Section. 2006, London, UK: Wiley-Blackwell Publishing Ltd.

• Editorial

  • Dear JW, Dargan PI, Juurlink DN, Thanacoody RHK, Wood DM. Introduction to a series of Pro/Con papers in Clinical Toxicology. British Journal of Clinical Pharmacology 2022, 88(1), 56-57.

• Letters

  • Bateman DN, Dear JW, Thanacoody HKR, Thomas SHL, Eddleston M. Treatment of paracetamol overdose Reply. Lancet 2014, 383(9926), 1383-1383.
  • Bateman DN, Dear JW, Thanacoody HKR, Thomas SHL, Eddleston M. Treatment of paracetamol overdose - Authors' reply. The Lancet 2014, 383(9926), 1383-1383.
  • Bateman DN, Thanacoody HK, Waring WS. Digitalis intoxication induced by paroxetine co-administration. Lancet 2006, 368, 1962-3.

• Note

  • Dear JW, Dargan PI, Eddleston M, Thanacoody RH, Thomas SHL. Response to the letter from Wong et al. EClinicalMedicine 2019, 14, 13-13.

• Online Publication

  • Thanacoody HKR. Opiate overdose. London, UK: BMJ Publishing Group, 2011. Available at: http://bestpractice.bmj.com/best-practice/monograph/339.html.

• Reviews

  • Motohashi K, Thanacoody RH. Toxicology in the emergency department: what's new?. British Journal of Hospital Medicine 2022, 83(9), 1-16.
  • Thompson JP, Watson ID, Thanacoody HKR, Morley S, Thomas SHL, Eddleston M, Vale JA, Bateman DN, Krishna CV. Guidelines for laboratory analyses for poisoned patients in the United Kingdom. Annals of Clinical Biochemistry 2014, 51(3), 312-325.
  • Thanacoody HKR, Thomas SHL. Tricyclic antidepressant poisoning: Cardiovascular toxicity. Toxicological Reviews 2005, 24(3), 205-214.
  • Bradberry SM, Thanacoody HKR, Watt BE, Thomas SHL, Vale JA. Management of the cardiovascular complications of tricyclic antidepressant poisoning: role of sodium bicarbonate. Toxicological Reviews 2005, 24(3), 195-204.
  • Thanacoody HKR, Thomas SHL. Antidepressant poisoning. Clinical Medicine 2003, 3(2), 114-118.